Prosecution Insights
Last updated: April 19, 2026

Glaxosmithkline Intellectual Property (No 2) Limited

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18571386 DAPRODUSTAT FOR REDUCING FATIGUE IN A SUBJECT WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE PATEL, SAGAR S 1626 Non-Final OA Dec 18, 2023
18031899 METHODS FOR TREATING CHOLESTATIC PRURITUS SZNAIDMAN, MARCOS L 1628 Non-Final OA Apr 14, 2023
18010245 FORMULATION COMPRISING DAPRODUSTAT TRAN, SUSAN T 1615 Non-Final OA Dec 14, 2022

Managing Glaxosmithkline Intellectual Property (No 2) Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month